Faes Farma SA (FAE) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.056x

Based on the latest financial reports, Faes Farma SA (FAE) has a cash flow conversion efficiency ratio of 0.056x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€43.90 Million ≈ $51.32 Million USD) by net assets (€777.46 Million ≈ $908.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see FAE market cap overview for the company's overall valuation and market capitalisation.

Faes Farma SA - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Faes Farma SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Faes Farma SA (FAE) stock price for real-time trading data and today's change.

Faes Farma SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Faes Farma SA ranked by their cash flow conversion efficiency. Review FAE cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
World Kinect Corporation
NYSE:WKC
-0.038x
Boston Beer Company Inc
NYSE:SAM
0.112x
Natural Resource Partners LP
NYSE:NRP
0.052x
Linea Directa Aseguradora SA Compania de Seguros y Reaseguros
MC:LDA
0.182x
Hillman Solutions Corp
NASDAQ:HLMN
0.087x
Pci-Suntek Technology Co Ltd
SHG:600728
0.008x
Golden Ocean Group Limited
F:KT31
-0.002x
PC Jeweller Limited
NSE:PCJEWELLER
0.004x

Annual Cash Flow Conversion Efficiency for Faes Farma SA (2005–2025)

The table below shows the annual cash flow conversion efficiency of Faes Farma SA from 2005 to 2025. Also see Faes Farma SA balance sheet assets for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €747.70 Million
≈ $874.14 Million
€78.49 Million
≈ $91.76 Million
0.105x -33.94%
2024-12-31 €726.62 Million
≈ $849.49 Million
€115.47 Million
≈ $134.99 Million
0.159x +4.40%
2023-12-31 €663.35 Million
≈ $775.52 Million
€100.97 Million
≈ $118.04 Million
0.152x -14.15%
2022-12-31 €602.28 Million
≈ $704.13 Million
€106.79 Million
≈ $124.85 Million
0.177x +19.78%
2021-12-31 €538.07 Million
≈ $629.06 Million
€79.64 Million
≈ $93.11 Million
0.148x -10.82%
2020-12-31 €472.88 Million
≈ $552.84 Million
€78.49 Million
≈ $91.76 Million
0.166x +1.59%
2019-12-31 €413.65 Million
≈ $483.60 Million
€67.58 Million
≈ $79.01 Million
0.163x -0.83%
2018-12-31 €360.15 Million
≈ $421.06 Million
€59.34 Million
≈ $69.37 Million
0.165x +26.65%
2017-12-31 €320.77 Million
≈ $375.02 Million
€41.73 Million
≈ $48.78 Million
0.130x -25.32%
2016-12-31 €284.89 Million
≈ $333.06 Million
€49.62 Million
≈ $58.02 Million
0.174x +8.29%
2015-12-31 €254.34 Million
≈ $297.34 Million
€40.91 Million
≈ $47.83 Million
0.161x +14.00%
2014-12-31 €228.63 Million
≈ $267.29 Million
€32.26 Million
≈ $37.71 Million
0.141x -11.81%
2013-12-31 €197.81 Million
≈ $231.26 Million
€31.65 Million
≈ $37.00 Million
0.160x +23.86%
2012-12-31 €184.82 Million
≈ $216.07 Million
€23.87 Million
≈ $27.91 Million
0.129x +8.38%
2011-12-31 €167.61 Million
≈ $195.96 Million
€19.98 Million
≈ $23.35 Million
0.119x +29.44%
2010-12-31 €165.51 Million
≈ $193.50 Million
€15.24 Million
≈ $17.81 Million
0.092x -33.21%
2009-12-31 €122.93 Million
≈ $143.71 Million
€16.95 Million
≈ $19.81 Million
0.138x -37.03%
2008-12-31 €156.71 Million
≈ $183.21 Million
€34.31 Million
≈ $40.11 Million
0.219x +153.53%
2007-12-31 €151.06 Million
≈ $176.60 Million
€13.04 Million
≈ $15.25 Million
0.086x -39.41%
2006-12-31 €139.85 Million
≈ $163.50 Million
€19.93 Million
≈ $23.30 Million
0.143x +40.54%
2005-12-31 €131.62 Million
≈ $153.88 Million
€13.35 Million
≈ $15.60 Million
0.101x --

About Faes Farma SA

MC:FAE Spain Drug Manufacturers - Specialty & Generic
Market Cap
$1.72 Billion
€1.47 Billion EUR
Market Cap Rank
#7488 Global
#64 in Spain
Share Price
€4.73
Change (1 day)
-0.94%
52-Week Range
€4.34 - €5.38
All Time High
€5.38
About

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants servic… Read more